HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Knud Nørregaard Hansen Selected Research

Thrombosis (Thrombus)

1/2021Influence of Plaque Characteristics on Early Vascular Healing in Patients With ST-Elevation Myocardial Infarction.
1/2020Clinical outcomes three-year after revascularization with biodegradable polymer stents: ultrathin-strut sirolimus-eluting stent versus biolimus-eluting stent: from the Scandinavian organization for randomized trials with clinical outcome VII trial.
2/2016Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents: 5-Year Results From SORT OUT IV.
1/2016Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial.
8/2014Three-year outcomes after revascularization with everolimus- and sirolimus-eluting stents from the SORT OUT IV trial.
6/2014Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.
11/2013Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results.
2/2013Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial.
12/2012Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial).
9/20122-year patient-related versus stent-related outcomes: the SORT OUT IV (Scandinavian Organization for Randomized Trials With Clinical Outcome IV) Trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Knud Nørregaard Hansen Research Topics

Disease

19Thrombosis (Thrombus)
01/2021 - 12/2008
18Myocardial Infarction
01/2020 - 12/2008
12Death (Near-Death Experience)
01/2020 - 02/2009
10ST Elevation Myocardial Infarction
01/2021 - 12/2008
8Cardiovascular Diseases (Cardiovascular Disease)
02/2016 - 02/2009
4Diabetes Mellitus
05/2014 - 02/2009
3Coronary Artery Disease (Coronary Atherosclerosis)
03/2012 - 02/2009
2Non-ST Elevated Myocardial Infarction
04/2017 - 11/2016
2Coronary Disease (Coronary Heart Disease)
02/2016 - 01/2010
1Hemorrhage
01/2020
1Spontaneous Remission
11/2016
1Pathologic Constriction (Stenosis)
08/2015
1Vascular Remodeling
05/2014
1Hyperplasia
05/2014
1Renal Insufficiency (Renal Failure)
02/2014
1Angina Pectoris
08/2012

Drug/Important Bio-Agent (IBA)

11Sirolimus (Rapamycin)FDA Link
01/2020 - 02/2009
5EverolimusFDA Link
08/2014 - 01/2010
3PolymersIBA
01/2021 - 02/2013
3omega-Chloroacetophenone (Mace)IBA
02/2016 - 08/2012
2MetalsIBA
01/2020 - 12/2008
2LipidsIBA
04/2017 - 02/2013
2zotarolimusIBA
06/2014 - 03/2010
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
02/2013 - 07/2012
2Rosuvastatin Calcium (Crestor)FDA Link
02/2013 - 07/2012
1BESIBA
01/2021
1Stainless Steel (Steel, Stainless)IBA
01/2020
1Sodium Bicarbonate (Baking Soda)FDA LinkGeneric
04/2014
1Acetylcysteine (Siran)FDA LinkGeneric
04/2014
1LDL CholesterolIBA
02/2013
1Paclitaxel (Taxol)FDA LinkGeneric
02/2009

Therapy/Procedure

24Stents
01/2021 - 12/2008
8Percutaneous Coronary Intervention
01/2021 - 12/2008
7Drug-Eluting Stents
01/2020 - 12/2008
1Therapeutics
02/2013